-
公开(公告)号:US20240247075A1
公开(公告)日:2024-07-25
申请号:US18505660
申请日:2023-11-09
Applicant: Genentech, Inc.
Inventor: Germaine FUH , Jenny M. Bostrom
CPC classification number: C07K16/32 , C07K16/22 , C07K16/2878 , C07K16/4283 , C07K16/468 , C07K2317/55 , C07K2317/56 , C07K2317/622 , C07K2317/73
Abstract: The invention provides multispecific antibodies and methods of making and using such antibodies.
-
公开(公告)号:US20210363231A1
公开(公告)日:2021-11-25
申请号:US17392943
申请日:2021-08-03
Applicant: Genentech, Inc.
Inventor: Amin FAMILI , Germaine FUH , Patrick KOENIG , Chingwei Vivian LEE , Karthikan RAJAGOPAL
Abstract: The present invention provides antibody conjugates that include antibodies (e.g., anti-VEGF antibodies) covalently linked to polymers (e.g., hyaluronic acid (HA) polymers), cysteine engineered antibodies, pharmaceutical compositions thereof, and uses thereof, for example for treatment of disorders associated with pathological angiogenesis (e.g., ocular disorders).
-
公开(公告)号:US20220033515A1
公开(公告)日:2022-02-03
申请号:US17232537
申请日:2021-04-16
Applicant: Genentech, Inc.
Inventor: Germaine FUH , Jenny M. BOSTROM
Abstract: The invention provides multispecific antibodies and methods of making and using such antibodies.
-
公开(公告)号:US20160257744A1
公开(公告)日:2016-09-08
申请号:US15167030
申请日:2016-05-27
Applicant: Genentech, Inc.
Inventor: Germaine FUH , Chingwei V. LEE , Patrick KOENIG
IPC: C07K16/24 , A61K39/395 , A61K45/06
Abstract: The invention provides dual specific antibodies and methods of making and using such antibodies. In general, the dual specific antibodies are generated by identification of a monospecific antibody having light chain variable region VL residues that are electrostatic or hydrophobic and altering the nucleic acid sequence encoding one or more solvent accessible residues in the VH of the antibody either alone or in combination with alteration of the nucleic acid sequence encoding the VL of the antibody. The altered VH and the VL are expressed and dual specific antibodies, or antigen-binding fragments thereof, are selected. Exemplary dual specific antibodies are also provided as well as methods of using the antibodies.
Abstract translation: 本发明提供了双重特异性抗体及其制备和使用方法。 通常,双特异性抗体通过鉴定具有静电或疏水性的轻链可变区VL残基的单特异性抗体并且改变编码抗体VH中一个或多个溶剂可及残基的核酸序列, 与编码抗体VL的核酸序列的改变的组合。 表达改变的VH和VL,并选择双特异性抗体或其抗原结合片段。 还提供了示例性的双特异性抗体以及使用抗体的方法。
-
公开(公告)号:US20150315290A1
公开(公告)日:2015-11-05
申请号:US14665697
申请日:2015-03-23
Applicant: Genentech, Inc.
Inventor: Jenny M. BOSTROM , Germaine FUH
IPC: C07K16/32 , A61K45/06 , A61K39/395 , C07K16/22
CPC classification number: C07K16/32 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/2863 , C07K2317/31 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/92 , C07K2317/94
Abstract: The invention provides multispecific antibodies and methods of making and using such antibodies.
Abstract translation: 本发明提供多特异性抗体以及制备和使用这些抗体的方法。
-
公开(公告)号:US20250109195A1
公开(公告)日:2025-04-03
申请号:US18980433
申请日:2024-12-13
Applicant: Genentech, Inc.
Inventor: Germaine FUH , Chingwei V. LEE , Patrick KOENIG
IPC: C07K16/24 , A61K39/00 , A61K39/395 , A61K45/06 , C07K16/46
Abstract: The invention provides dual specific antibodies and methods of making and using such antibodies. In general, the dual specific antibodies are generated by identification of a monospecific antibody having light chain variable region VL residues that are electrostatic or hydrophobic and altering the nucleic acid sequence encoding one or more solvent accessible residues in the VH of the antibody either alone or in combination with alteration of the nucleic acid sequence encoding the VL of the antibody. The altered VH and the VL are expressed and dual specific antibodies, or antigen-binding fragments thereof, are selected. Exemplary dual specific antibodies are also provided as well as methods of using the antibodies.
-
公开(公告)号:US20240279327A1
公开(公告)日:2024-08-22
申请号:US18648653
申请日:2024-04-29
Applicant: Genentech, Inc.
Inventor: Germaine FUH , Chingwei V. LEE , Patrick KOENIG
IPC: C07K16/24 , A61K39/00 , A61K39/395 , A61K45/06 , C07K16/46
CPC classification number: C07K16/244 , A61K39/3955 , A61K45/06 , C07K16/247 , C07K16/468 , A61K2039/505 , C07K2317/14 , C07K2317/21 , C07K2317/31 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/92
Abstract: The invention provides dual specific antibodies and methods of making and using such antibodies. In general, the dual specific antibodies are generated by identification of a monospecific antibody having light chain variable region VL residues that are electrostatic or hydrophobic and altering the nucleic acid sequence encoding one or more solvent accessible residues in the VH of the antibody either alone or in combination with alteration of the nucleic acid sequence encoding the VL of the antibody. The altered VH and the VL are expressed and dual specific antibodies, or antigen-binding fragments thereof, are selected. Exemplary dual specific antibodies are also provided as well as methods of using the antibodies.
-
公开(公告)号:US20210244815A1
公开(公告)日:2021-08-12
申请号:US17229999
申请日:2021-04-14
Applicant: Genentech, Inc.
Inventor: Chingwei Vivian LEE , Mark S. DENNIS , Germaine FUH
IPC: A61K39/395 , C07K16/28 , C07K16/30 , A61P35/00 , C07K14/725
Abstract: The invention provides anti-cluster of differentiation 3 (CD3) antibodies and methods of using the same.
-
公开(公告)号:US20200255512A1
公开(公告)日:2020-08-13
申请号:US16860891
申请日:2020-04-28
Applicant: Genentech, Inc.
Inventor: Germaine FUH , Chingwei V. LEE , Patrick KOENIG
IPC: C07K16/24 , C07K16/46 , A61K45/06 , A61K39/395
Abstract: The invention provides dual specific antibodies and methods of making and using such antibodies. In general, the dual specific antibodies are generated by identification of a monospecific antibody having light chain variable region VL residues that are electrostatic or hydrophobic and altering the nucleic acid sequence encoding one or more solvent accessible residues in the VH of the antibody either alone or in combination with alteration of the nucleic acid sequence encoding the VL of the antibody. The altered VH and the VL are expressed and dual specific antibodies, or antigen-binding fragments thereof, are selected. Exemplary dual specific antibodies are also provided as well as methods of using the antibodies.
-
公开(公告)号:US20200002411A1
公开(公告)日:2020-01-02
申请号:US16572822
申请日:2019-09-17
Applicant: Genentech, Inc.
Inventor: Amin FAMILI , Germaine FUH , Patrick KOENIG , Chingwei Vivian LEE , Karthikan RAJAGOPAL
Abstract: The present invention provides antibody conjugates that include antibodies (e.g., anti-VEGF antibodies) covalently linked to polymers (e.g., hyaluronic acid (HA) polymers), cysteine engineered antibodies, pharmaceutical compositions thereof, and uses thereof, for example for treatment of disorders associated with pathological angiogenesis (e.g., ocular disorders).
-
-
-
-
-
-
-
-
-